These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 24047815

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rivaroxaban for treatment of venous thromboembolism in older adults.
    Mitchell AP, Conway SE.
    Consult Pharm; 2014 Sep; 29(9):627-30. PubMed ID: 25203412
    [Abstract] [Full Text] [Related]

  • 24. Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.
    Fermann GJ, Erkens PM, Prins MH, Wells PS, Pap ÁF, Lensing AW.
    Acad Emerg Med; 2015 Mar; 22(3):299-307. PubMed ID: 25716463
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
    Oberhofer E.
    MMW Fortschr Med; 2015 Jan 19; 157(1):24. PubMed ID: 25743289
    [No Abstract] [Full Text] [Related]

  • 27. A clinical perspective of venous thromboembolism.
    Moll S.
    Arterioscler Thromb Vasc Biol; 2008 Mar 19; 28(3):373-9. PubMed ID: 18296592
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Safety and efficacy of rivaroxaban for thromboprophylaxis following lower limb surgery: an update.
    Goff T, Kontakis G, Giannoudis PV.
    Expert Opin Drug Saf; 2011 Sep 19; 10(5):687-96. PubMed ID: 21406027
    [Abstract] [Full Text] [Related]

  • 30. [Direct acting oral anticoagulants in venous thromboembolism].
    Walti C, Bächli E.
    Praxis (Bern 1994); 2015 Jul 22; 104(15):771-80. PubMed ID: 26204334
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Comments on the guidelines of the European Society of Cardiology Task Force on pulmonary embolism].
    Zonzin P, Agnelli G, Casazza F, Favretto G, Giuntini C, Morpurgo M, Vizza CD.
    Ital Heart J Suppl; 2001 Dec 22; 2(12):1342-56. PubMed ID: 11838358
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism: drip, drug, and discharge.
    Sharifi M, Bay C, Schwartz F, Skrocki L.
    Clin Cardiol; 2014 Feb 22; 37(2):78-82. PubMed ID: 24122947
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical management of rivaroxaban-treated patients.
    Palareti G, Ageno W, Ferrari A, Filippi A, Imberti D, Pengo V, Rubboli A, Toni D.
    Expert Opin Pharmacother; 2013 Apr 22; 14(5):655-67. PubMed ID: 23414291
    [Abstract] [Full Text] [Related]

  • 37. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT, Dobromirski M, Gurwith MM.
    Thromb Res; 2014 Feb 22; 133(2):139-48. PubMed ID: 24182642
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Venous thromboembolism: diagnosis and current anticoagulation strategies for deep vein thrombosis and pulmonary embolism.
    Pascarella L, Cox MW, O'Brien PJ.
    Hosp Pract (1995); 2012 Aug 22; 40(3):58-70. PubMed ID: 23086095
    [Abstract] [Full Text] [Related]

  • 40. Anticoagulation with rivaroxaban: covering a broad spectrum of thromboembolic disease.
    Schellong S.
    Expert Rev Cardiovasc Ther; 2013 Jul 22; 11(7):817-28. PubMed ID: 23895025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.